KRAS and adenocarcinoma: ALK-positive NSCLC patients were mostly non-smokers or light smokers and relatively young, had adenocarcinoma, and generally did not exhibit gene mutations such as the EGFR and Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations [26].